STEPS Trial - Spheramine Safety and Efficacy Study

Stopped Study was completed, only life long extended follow-up phase was discontinued after 12 years.

Conditions

• Parkinson Disease

Interventions

• BIOLOGICAL: Spheramine (BAY86-5280)
• PROCEDURE: Placebo

Sponsor

Bayer

Collaborators

• [object Object]